
Colgate-Palmolive (CL) Stock Forecast & Price Target
Colgate-Palmolive (CL) Analyst Ratings
Bulls say
Colgate-Palmolive is positioned to benefit from a quality 3Q beat-and-raise, with organic sales up 3.6% driven by Emerging Markets growth of 5.4% and operating leverage from 1.7% volume/mix gains that lifted gross margin and EPS. Its bull case is reinforced by international strength across LatAm, APAC, and EMEA, Hill’s Pet Nutrition growth of 5.7%, and management’s ability to execute productivity programs that support FY26 gross margin of 60.4% and EPS growth of 6%. Although North America remains a work in progress, early signs of toothpaste share improvement, a more favorable category backdrop, and a stronger 2027 innovation pipeline suggest the company can sustain momentum while narrowing its share gap.
Bears say
Colgate-Palmolive is facing a fundamental earnings-quality problem because its North America business remains a growth drag, with Q3 organic sales down 1.6% and volumes down 3%, while the division’s operating margin fell 210 bps year over year to 19.5%. The company also appears structurally disadvantaged in oral care, where competition from P&G and Haleon has exposed innovation gaps in whitening and premium therapeutics, and its broader toothpaste portfolio is priced below premium peers, limiting mix and margin upside. On top of that, elevated commodity, freight, and logistics costs are expected to persist into 2027, while emerging-market currency volatility and recessionary pressure could further weigh on top-line growth and profitability.
This aggregate rating is based on analysts' research of Colgate-Palmolive and is not a guaranteed prediction by Public.com or investment advice.
Colgate-Palmolive (CL) Analyst Forecast & Price Prediction
Start investing in Colgate-Palmolive (CL)
Order type
Buy in
Order amount
Est. shares
0 shares
FAQs About Colgate-Palmolive (CL) Forecast
Colgate-Palmolive (CL) Analyst Forecast & Price Prediction
Start investing in Colgate-Palmolive (CL)
Order type
Buy in
Order amount
Est. shares
0 shares